Literature DB >> 3455647

Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986.

S Slopek1, B Weber-Dabrowska, M Dabrowski, A Kucharewicz-Krukowska.   

Abstract

In the years 1981-1986 bacteriophage therapy was applied in 550 cases (100 treated in 1986) of suppurative bacterial infections. Positive results were obtained in 508 cases (92.4%). In 38 cases (6.9%) a transient improvement was observed and in 4 cases (0.7%) phage treatment proved ineffective. Considering that majority of patients (518 cases, 94.2%) were resistant to antibiotic treatment, the results of phage therapy may be regarded as favorable.

Entities:  

Mesh:

Year:  1987        PMID: 3455647

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  50 in total

Review 1.  Bacteriophage therapy.

Authors:  A Sulakvelidze; Z Alavidze; J G Morris
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 2.  Pharmacokinetic principles of bacteriophage therapy.

Authors:  Robert J H Payne; Vincent A A Jansen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice.

Authors:  Ryohei Watanabe; Tetsuya Matsumoto; Go Sano; Yoshikazu Ishii; Kazuhiro Tateda; Yoshinobu Sumiyama; Jumpei Uchiyama; Shingo Sakurai; Shigenobu Matsuzaki; Shosuke Imai; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

4.  Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control.

Authors:  S C Park; I Shimamura; M Fukunaga; K I Mori; T Nakai
Journal:  Appl Environ Microbiol       Date:  2000-04       Impact factor: 4.792

5.  Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves.

Authors:  P Barrow; M Lovell; A Berchieri
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

6.  Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis.

Authors:  John J Curtin; Rodney M Donlan
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

7.  Long-circulating bacteriophage as antibacterial agents.

Authors:  C R Merril; B Biswas; R Carlton; N C Jensen; G J Creed; S Zullo; S Adhya
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

8.  Phage Therapy - Everything Old is New Again.

Authors:  Andrew M Kropinski
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

9.  Antibacterial efficacy of temperate phage-mediated inhibition of bacterial group motilities.

Authors:  In-Young Chung; Nuri Sim; You-Hee Cho
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

Review 10.  Topical application of bacteriophages for treatment of wound infections.

Authors:  Rachel Yoon Kyung Chang; Sandra Morales; Yuko Okamoto; Hak-Kim Chan
Journal:  Transl Res       Date:  2020-03-19       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.